tiprankstipranks
Trending News
More News >
Cormedix (CRMD)
NASDAQ:CRMD
US Market

Cormedix (CRMD) Ratios

Compare
1,674 Followers

Cormedix Ratios

CRMD's free cash flow for Q4 2025 was $0.83. For the 2025 fiscal year, CRMD's free cash flow was decreased by $ and operating cash flow was $0.43. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.01 2.01 3.39 6.97 9.44
Quick Ratio
1.84 1.84 3.16 6.78 9.44
Cash Ratio
0.84 0.84 1.20 3.83 6.87
Solvency Ratio
0.42 0.42 -0.52 -3.88 -4.23
Operating Cash Flow Ratio
1.00 1.00 -1.50 -3.37 -3.86
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
$ -70.37M$ -70.37M$ 80.39M$ 67.53M$ 52.57M
Leverage Ratios
Debt-to-Assets Ratio
0.18 0.18 <0.01 <0.01 0.01
Debt-to-Equity Ratio
0.37 0.37 <0.01 <0.01 0.01
Debt-to-Capital Ratio
0.27 0.27 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.26 0.26 0.00 0.00 0.00
Financial Leverage Ratio
2.04 2.04 1.40 1.17 1.13
Debt Service Coverage Ratio
64.04 64.04 -483.01 0.00 -1.11K
Interest Coverage Ratio
53.97 53.97 -614.10 0.00 -1.15K
Debt to Market Cap
0.29 0.17 0.00 0.00 0.00
Interest Debt Per Share
1.92 2.11 <0.01 0.01 0.02
Net Debt to EBITDA
0.02 0.02 2.11 0.93 1.42
Profitability Margins
Gross Profit Margin
88.46%88.46%92.66%0.00%94.29%
EBIT Margin
48.17%48.17%-44.37%0.00%-46264.69%
EBITDA Margin
52.98%52.98%-43.66%0.00%-45945.10%
Operating Profit Margin
48.17%48.17%-51.43%0.00%-46819.91%
Pretax Profit Margin
48.13%48.13%-44.45%0.00%-46305.23%
Net Profit Margin
52.31%52.31%-41.24%0.00%-45409.90%
Continuous Operations Profit Margin
52.31%52.31%-41.24%0.00%-45409.90%
Net Income Per EBT
108.69%108.69%92.78%100.00%98.07%
EBT Per EBIT
99.92%99.92%86.44%94.65%98.90%
Return on Assets (ROA)
19.74%19.74%-15.09%-56.47%-47.88%
Return on Equity (ROE)
58.50%40.23%-21.18%-66.06%-53.94%
Return on Capital Employed (ROCE)
23.03%23.03%-26.30%-69.29%-54.95%
Return on Invested Capital (ROIC)
24.90%24.90%-24.35%-69.14%-53.76%
Return on Tangible Assets
39.10%39.10%-15.32%-56.47%-47.88%
Earnings Yield
32.83%19.46%-3.76%-24.21%-17.54%
Efficiency Ratios
Receivables Turnover
1.82 1.82 0.84 0.00 0.00
Payables Turnover
4.56 4.56 1.85 0.05 <0.01
Inventory Turnover
1.21 1.21 0.42 0.10 0.00
Fixed Asset Turnover
0.00 31.41 18.73 0.00 0.03
Asset Turnover
0.38 0.38 0.37 0.00 <0.01
Working Capital Turnover Ratio
2.06 2.43 0.58 0.00 <0.01
Cash Conversion Cycle
422.10 422.10 1.11K -3.86K -215.26K
Days of Sales Outstanding
200.51 200.51 433.69 0.00 0.00
Days of Inventory Outstanding
301.62 301.61 869.39 3.74K 0.00
Days of Payables Outstanding
80.02 80.02 196.79 7.60K 215.26K
Operating Cycle
502.12 502.12 1.30K 3.74K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
2.22 2.43 -0.86 -0.75 -0.61
Free Cash Flow Per Share
2.21 2.40 -0.86 -0.76 -0.61
CapEx Per Share
<0.01 0.03 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 0.99 1.00 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
299.64 77.45 -437.35 -117.35 -111.04
Capital Expenditure Coverage Ratio
299.64 77.45 -437.35 -117.35 -111.04
Operating Cash Flow Coverage Ratio
1.18 1.18 -97.90 -57.53 -30.35
Operating Cash Flow to Sales Ratio
0.56 0.56 -1.16 0.00 -372.38
Free Cash Flow Yield
35.03%20.62%-10.64%-20.24%-14.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
3.05 5.14 -26.60 -4.13 -5.70
Price-to-Sales (P/S) Ratio
1.60 2.69 10.97 0.00 2.59K
Price-to-Book (P/B) Ratio
1.23 2.07 5.63 2.73 3.08
Price-to-Free Cash Flow (P/FCF) Ratio
2.85 4.85 -9.40 -4.94 -6.89
Price-to-Operating Cash Flow Ratio
2.84 4.79 -9.42 -4.98 -6.95
Price-to-Earnings Growth (PEG) Ratio
-1.71 >-0.01 0.40 -0.18 4.28
Price-to-Fair Value
1.23 2.07 5.63 2.73 3.08
Enterprise Value Multiple
3.03 5.09 -23.01 -3.21 -4.22
Enterprise Value
501.11M 840.84M 436.73M 148.42M 126.81M
EV to EBITDA
3.03 5.09 -23.01 -3.21 -4.22
EV to Sales
1.61 2.70 10.05 0.00 1.94K
EV to Free Cash Flow
2.87 4.87 -8.61 -3.83 -5.16
EV to Operating Cash Flow
2.86 4.80 -8.63 -3.86 -5.21
Tangible Book Value Per Share
-0.05 -0.05 1.41 1.38 1.37
Shareholders’ Equity Per Share
5.14 5.63 1.44 1.38 1.37
Tax and Other Ratios
Effective Tax Rate
-0.09 -0.09 0.07 0.00 0.02
Revenue Per Share
3.95 4.33 0.74 0.00 <0.01
Net Income Per Share
2.07 2.26 -0.30 -0.91 -0.74
Tax Burden
1.09 1.09 0.93 1.00 0.98
Interest Burden
1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.06 0.06 0.09 0.00 163.28
SG&A to Revenue
0.22 0.22 0.69 0.00 0.00
Stock-Based Compensation to Revenue
0.06 0.00 0.14 0.00 62.22
Income Quality
1.07 1.07 2.82 0.83 0.82
Currency in USD